Proton therapy in two sessions for prostate cancer
Part of Cancer clinical trials.
This trial tests if giving proton radiation in just two sessions, guided by MRI, is safe and effective for low- or intermediate-risk prostate cancer. It may mean fewer trips to the hospital for treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have low- or intermediate-risk prostate cancer that has not spread to lymph nodes or other parts of the body.
- You need to be able to have an MRI scan (for example, no pacemaker or other implanted device that prevents it).
- You cannot have had previous radiation therapy to the pelvis, chemotherapy, or surgery like prostate removal for your cancer.
- You should not have had a transurethral resection of the prostate (TURP) in the last 8 weeks.
- You must not have had more than 6 months of hormone therapy (androgen deprivation therapy) for your prostate cancer.
- You cannot have a hip replacement or a prostate larger than 100cc on MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
This study tests a very short course (ultrahypofractionated) of proton beam radiation for localized prostate cancer. It aims to see if it's safe and effective with fewer treatment visits.
This trial tests a new way to give prostate radiation using just 3 sessions with a special guidance system (RayPilot HypoCath) to target the tumor more accurately and safely.
This trial tests proton radiation therapy for people with high-risk prostate cancer. It may help by delivering radiation in a more targeted way, with the goal of controlling the cancer while reducing exposure to nearby healthy tissue.
This trial tests a very short, one-time form of radiation (SBRT) to treat prostate cancer. It aims to see whether treating the prostate in one shot is safe and effective for carefully selected patients.
This trial tests whether giving prostate radiation in one treatment session can work well while protecting the bladder. It may help certain people with localized prostate cancer by aiming for good cancer control with fewer bladder/urinary side effects.
Hear when a new Prostate Cancer Patients Treated by Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.